Related Experiment Video
Updated: May 18, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Arrhythmogenic right ventricular cardiomyopathy: an update on pathophysiology, genetics, diagnosis, and risk
1Division of Cardiology, Department of Cardiovascular Medicine, University Hospital Münster, Albert-Schweitzer-Campus 1 (Gebäude A1), 48149, Münster, Germany. Matthias.Paul@ukmuenster.de
Insights
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart condition causing dangerous arrhythmias and sudden death. Genetic factors are key, but diagnosis and prognosis remain challenging.
Area of Science:
- Cardiology
- Genetics
- Inherited Diseases
Background:
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy linked to sudden cardiac death in young individuals.
- Mutations in desmosomal genes are recognized as primary causes of ARVC.
- Genetic heterogeneity and variable clinical presentation complicate prognostic assessments.
Purpose of the Study:
- To provide a comprehensive review of the current literature on ARVC.
- To discuss the pathogenesis, diagnosis, treatment, and prognosis of ARVC.
- To highlight potential future developments in ARVC research and management.
Main Methods:
- Literature review of scientific articles on ARVC.
- Analysis of current diagnostic criteria and risk stratification methods.
- Synthesis of information on genetic factors and clinical manifestations.
Main Results:
- Desmosomal gene mutations are established causes of ARVC.
- Despite advancements, underdiagnosis and misdiagnosis of ARVC persist.
- Established diagnostic criteria (WHO 1995, modified 2010) aid in ARVC identification.
Conclusions:
- ARVC diagnosis and prognosis remain challenging due to genetic complexity and variable expression.
- Accurate diagnosis and risk stratification are crucial for managing ARVC patients.
- Ongoing research is vital for improving understanding and treatment of ARVC.
Abstract:
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy accounting for life-threatening ventricular tachyarrhythmias and sudden death in young individuals and athletes. Over the past years, mutations in desmosomal genes have been identified as disease-causative. However, genetic heterogeneity and variable phenotypic expression alongside with diverse disease progression still render the evaluation of its prognostic implication difficult. ARVC was initially entered into the canon of cardiomyopathies of the World Health Organization in 1995, and international efforts have resulted in the 2010 modified diagnostic criteria for ARVC. Despite all additional insights into pathophysiology, clinical management, and modern risk stratification, under-/misdiagnosing of ARVC remains a problem and hampers reliable statements on the incidence, prevalence, and natural course of the disease.This review provides a comprehensive overview of the current literature on the pathogenesis, diagnosis, treatment, and prognosis of ARVC and sheds some light on potential new developments in these areas.
More Related Videos
10:18Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice
Published on: February 1, 2022
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Dysrhythmias V: Evaluating Dysrhythmias